These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Slow-binding inhibition of 6-phosphogluconate dehydrogenase by zinc ion.
    Author: Niehaus WG, Richardson SB, Wolz RL.
    Journal: Arch Biochem Biophys; 1996 Sep 15; 333(2):333-7. PubMed ID: 8809071.
    Abstract:
    6-Phosphogluconate dehydrogenase (EC 1.1.1.44) has been purified from Cryptococcus neoformans, an encapsulated yeast that is an opportunistic pathogen of AIDS patients. The dimeric enzyme had a subunit molecular weight of 50,000, a specific activity of 50 units mg-1, and Km values of 13 microM for 6-phosphogluconate and 0.89 microM for NADP. This enzyme, like many fungal dehydrogenases, was inhibited by Zn2+, with the inhibition pattern being competitive versus the nonnucleotide substrate. In the presence of micromolar Zn2+, the reaction was biphasic, with the reduction of NADP proceeding initially at the control rate, but, over the time course of 20-300 s, this initial nonlinear phase reached a final, linear steady state with a slower velocity. This pattern is indicative of a slow binding inhibition process, for which we have calculated the following kinetic constants: k6, the limiting rate constant for the transition from initial to final steady state was 0.0024 s-1, corresponding to a half-time of 300 s; Ki*, the overall equilibrium constant for the dissociation of E*Zn2+ to E + Zn2+ was 0.021 microM.
    [Abstract] [Full Text] [Related] [New Search]